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Middleearacquiredcholesteatomaisapathologicalconditionassociatedwithotitismedia,whichmaybeassociatedwithtemporal
bone resorption, otorrhea and hearing loss, and occasionally various other complications. Cholesteatoma is characterized by
the enhanced proliferation of epithelial cells with aberrant morphologic characteristics. Unfortunately, our understanding of the
mechanism underlying its pathogenesis is limited. To investigate its pathogenesis, diﬀerent animal models have been used. This
paper provides a brief overview of the current status of research in the ﬁeld of pathogenesis of middle ear acquired cholesteatoma,
four types of animal models previously reported on, up-to-date cholesteatoma research using these animal models, our current
studies of the local hybrid ear model, and the future prospect of new animal models of middle ear cholesteatoma.
1.Introduction
Middle ear acquired cholesteatoma is a pathological condi-
tion associated with otitis media [1, 2], and as the cause
of otorrhea, hearing loss, and occasionally complications
such as facial palsy [3], brain abscess, and meningitis
[4]. Recurrence after surgical treatment is very common
[5]. Middle ear acquired cholesteatoma is morphologically
characterized by epithelial cell proliferation and granulation
tissue formation. Unfortunately, despite many studies our
understandingofthemechanismsunderlyingthepathogene-
sis of cholesteatoma is limited. Four predominant theories of
the genesis of cholesteatoma formation have been proposed.
(1) Metaplasia Theory. in 1873, Wendt [6] suggested that
metaplasia of the mucosa of the middle ear into the kera-
tinizing epithelium led to cholesteatoma. Sad´ e et al. [7, 8]
proposed thatchronicirritation cancausethemucosallining
of the middle ear to convert to a keratinizing epithelium.
(2) Immigration Theory. Bezold in 1890 [9]a n dH a b e r m a n n
[10] described immigration theory. Friedmann [11]a n d
Tumarkin [12] have been more contemporary supporters
of this aspect, which proposed that squamous epithelium
migrates through a defect in the tympanic membrane in an
eﬀort to cover areas of inﬂammation in the middle ear.
(3) Hyperplasia Theory. R¨ uedi [13] presented evidence that
supported the basal cell hyperplasia (papillary proliferation)
theory ﬁrst published by Manasse et al. [14] in 1917. As the
result of inﬂammation of the middle ear, the proliferation
of epithelial cones in the basal layers of the keratinizing
epithelium of Shrapnell’s membrane leads to cholesteatoma
formation.
(4) Retraction Pocket Theory. Bezold in 1890 [9]ﬁ r s t
described this currently most-accepted theory that proposes
that acquired cholesteatoma develops from retraction pock-
ets [15]. A retraction of Shrapnell’s membrane as a result of
chronic dysfunction of the Eustachian tube might progress
into cholesteatoma formation.
4(a) Habitual sniﬃng theory was described as under
the heading of retraction theory. Habitual sniﬃng2 Journal of Biomedicine and Biotechnology
associated with closing failure of the Eustachian tube
is believed to be closely related to the etiology of
retraction-type cholesteatoma [16–18]. It seems that
such sniﬃng induces a high negative pressure in
the middle ear and may sometimes promote the
development of cholesteatoma or its recurrence after
surgery [19, 20].
Currently, the retraction pocket theory has many sup-
porters following clinical observation, and there is clinical
evidence for the “retraction and proliferation theory” on the
pathogenesisofcholesteatoma[21,22].SudhoﬀandTos[23]
suggested the proliferation of epithelial cells in the retraction
pocket was altered by inﬂammatory stimuli of the subep-
ithelial connective tissue and that this excessive proliferation
may ﬁnally lead to cholesteatoma formation. They proposed
a four-step concept for the pathogenesis of cholesteatoma
that combined the retraction and proliferation theories: (a)
the retraction pocket stage, (b) the proliferation stage of the
retraction pocket, subdivided into cone formation and cone
fusion, (c) the expansion stage of attic cholesteatoma, and
(d) bone resorption (Figure 1,[ 24]). But, there was a lack
of explanation for the transition from a retraction pocket to
cholesteatoma.
Animal models are very important for studying the
pathogenesis of acquired cholesteatoma [25–27]. Chin-
chillas, guinea pigs, Mongolian gerbils, Meriones unguic-
ulatus, and rats have been used to make animal models
of cholesteatoma. In several studies, chinchillas were used
because their auditory apparatus is similar to that of humans
[28]. On the other hand, pigs were used for temporal
bone pneumatization models because they have a mastoid
(Figure 2)[ 29]. The gerbil is the only nonhuman animal
known to spontaneously develop aural cholesteatomas [25,
30]. The ultrastructure of the epithelial and subepithelial
linings of the gerbilline middle ear are similar to that of
the human [31], and destructive characteristics of the ger-
billine cholesteatoma closely mimic human cholesteatoma
[32]. Chole et al. [25] indicated that aural cholesteatoma
were found to arise spontaneously in 45.7% of gerbilline
ears studied. Henry et al. [30] indicated that both the
prevalence of spontaneous cholesteatoma and the resultant
peripheral auditory evoked potential threshold increased
from 6 to 18 months of age. Chole et al. [25] and Henry
et al. [30] described ﬁve stages of spontaneous gerbilline
cholesteatomas (Figure 3,[ 30]). Stage I is an accumulation
of keratin debris on the outside surface of the tympanic
membrane; stage II has a medial displacement of the
tympanic membrane into middle ear without contact with
the middle wall of the bulla; stage III, the cholesteatoma is
in contact with the prominence of the cochlea; in stage IV,
cholesteatoma ﬁlls the bulla; in stage V, the cholesteatoma
extends intracranially. The stage of development of the
cholesteatoma varied as a function of age. Most of the
aﬀected 6- and 12-month-old gerbils (younger gerbils) had
stage I or II cholesteatomas. More than half of the 18- and
24-month-old gerbils (older gerbils) had stage III or stage IV
cholesteatomas. Some of the oldest gerbils were at stage V,
with the cranial cavity being invaded. Also, in 2006, Tinling
(a) (b)
(c) (d)
Figure 1: Schematic illustration of the expansion stage written by
Sudhoﬀ and Tos [24]. (a) Expansion of sinus cholesteatoma, and
the lakes of keratin are opened to the surface of the retraction
wall in the depth the cones are proliferating and growing. Lateral
migration and cell cleaning is superﬁcially still possible (arrow)
(reproduced with modiﬁcation with permission from [24]). (b)
The cholesteatoma has expanded by the length of the cone. In the
depth, new microcholesteatoma are formed within the new cones
(reproducedwithmodiﬁcationwithpermissionfrom[24]).(c)The
keratin lakes are fused, moving the border of the matrix further
towards the attic (reproduced with modiﬁcation with permission
from [24]). (d) Further expansion of attic cholesteatoma. Estab-
lishment of a vicious circle in the following ways: proliferation
at the bottom of the cone, keratin formation within the cones,
fusions of microcholesteatomas, and further accumulation of
keratin leading to further deterioration of cell cleaning (reproduced
with modiﬁcation with permission from [24]).
and Chole [33] investigated the migration rate and patterns
for keratin on the tympanic membrane of the gerbil and
guinea pig in comparison to human data and indicated
that the gerbil was an appropriate model for cholesteatoma
because gerbils quite closely resemble humans in rate and
pattern of epithelial migration.
In this paper, we summarize the described models for
experimentally induced cholesteatoma and introduce our
animal models.Journal of Biomedicine and Biotechnology 3
Figure 2: Macroscopically photos of the largest section of the mas-
toid process in pig (reproduced with modiﬁcation with permission
from I Friedmann [29]).
2. Ligation of the ExternalEar CanalModel in
the Mongolian Gerbil
Although the spontaneous gerbilline cholesteatoma [30]i s
useful for studying the pathogenesis of cholesteatoma, the
experimental ligation technique of the external ear canal
in gerbils is more valuable in predicting the stage of the
cholesteatoma [26, 34]. Mongolian gerbils between 2 and
6 months of age were used in this experiment. Under
anesthesia, the ear canal was ligated through a curvilinear
incision behind the pinna. These experimentally induced
cholesteatomas developed in 100% of the ligated ears. Some
6–9monthsafterligationoftheexternalauditorycanal,these
cholesteatomas are in contact with the bone of the middle
ear. These induced cholesteatomas were seen to erode bone
and displace soft tissue structures, as is typical of human
aural cholesteatomas (Figure 4,[ 26]). From a surgical point
of view, this model is easy to handle, with a high percentage
of success. This animal model has been proved to be useful
and informative regarding retraction pocket formation and
cholesteatoma development.
Several studies were done using this model. In 1999,
Kim and Chung [35] examined the distribution of cytok-
eratin and the binding patterns of lectin in experimental
cholesteatoma specimens. They concluded that the origin
of aural cholesteatoma may be the external auditory canal
epidermal cells, and the characteristics of these cells do not
changeoncethecholesteatomadevelops.Theyalsosuggested
that cholesteatoma have a diﬀerent biological nature from
that of normal epithelial cells, especially basal cells. Larsson
et al. [36] performed the acoustic admittance measurements
and morphological analysis in experimental cholesteatoma
and tympanic membrane. They indicated that the thickness
of the ﬁbrous layer was almost doubled, mostly because of
an increased amount of collagen ﬁbers, and the acoustic
stiﬀness was signiﬁcantly increased in all cholesteatoma ears.
Park et al. investigated the immunohistochemical study of
cellproliferationusingBrdUlabeling[37]andtheexpression
of PLG-gamma1, ligand-mediated signal transduction for
cell proliferation [38] on the tympanic membrane, exter-
nal auditory canal, and induced cholesteatoma in gerbils.
According to the results, the induced aural cholesteatoma
showed a more active proliferation center of the epithelial
cell and more intense immunolabeling of PLG-gamma1
protein than the eardrum and external ear canal of the
normal gerbil. Tinling and Chole [39] also indicated the
hyperproliferation of kertinocytes to be a causative factor
in the development and progression of spontaneous and
experimental cholesteatomas in this gerbilline model.
3.EustachianTubeBlockingModelinthe
Mongolian Gerbil
The cornerstone of the retraction pocket theory is that
Eustachian tube obstruction leads to negative middle ear
pressure, middle ear eﬀusion, and retraction of the pars ﬂac-
cida into the epitympanum, and subsequent cholesteatoma.
To evaluate the evidence of this theory, the Eustachian tube
blocking model was developed by Wolfman and Chole in
1986 [27]. Bilateral Eustachian tube obstruction by electro-
cauterization of the nasopharyngeal portion was performed
in gerbils.
Mongolian gerbils between 6 to 10 weeks of age were
used in this experiment. After each animal was anesthetized,
they attempted to gain exposure of the tubal oriﬁce by
slitting the soft palate in the midline (Figure 5(a),[ 27]).
A cautery tip was then inserted through the soft palate in
the midline and rotated so as to contact the right and left
nasopharyngeal walls, respectively (Figure 5(b),[ 27]). The
results of their study were as follows (Figure 6,[ 27]). At
two weeks, all animals had bilateral serous eﬀusions and
retraction pockets. At four weeks, four of eight ears had
middle ear ﬂuid, retractions, and cholesteatomas. After eight
weeks, ﬁve of eight ears had middle ear eﬀusions, and four of
these had cholesteatomas; one ear had total atelectasis with a
cholesteatoma ﬁlling the bulla. By 16 weeks, six of eight ears
had developed cholesteatomas.
This study provides experimental evidence that aural
cholesteatomas may arise by retraction of the tympanic
membrane. In 2001, they suggested that the expression
pattern of cytokeratin in retraction pocket cholesteatoma is
diﬀerent from that in normal skin and that the transmigra-
tion and hyperproliferation process of squamous epithelium
occurs in areas adjacent to the aural cholesteatoma [40].
Using this model, Wilmoth et al. [41] suggested that the
elevation of tumor necrosis factor-alpha and matrix metallo-
proteinases associated with progressive tympanic membrane
atelectasis indicated a possible role for these inﬂammatory
mediators in the pathogenesis of cholesteatoma.
4.Chemical Injectioninto the Middle Earin
theChinchilla,GuineaPig,andRat
It was known that chemical injection into the middle ear led
totheoccurrenceofinﬂammatorychangeandcholesteatoma4 Journal of Biomedicine and Biotechnology
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Figure 3: Stages of gerbilline cholesteatoma (reproduced with modiﬁcation with permission from Henry et al. [30]). Stage I is accumulation
of keratin debris on outside surface of tympanic membrane; stage II is medial displacement of tympanic membrane into middle ear without
contact with middle wall of bulla; stage III is contact of cholesteatoma with prominence of cochlea (arrows point to early bone erosion);
stage is IV cholesteatoma ﬁlling bulla; stage V (not shown) intracranial extension of cholesteatoma (reproduced with modiﬁcation with
permission from [30]).
C
Figure 4: Photograph of gerbilline middle ear 2 months after
ligation of external auditory canal (reproduced with modiﬁcation
with permission from McGinn et al. [26]). The cholesteatoma
has eroded the bone of the tympanic annulus (arrows) and is
bulgingtowardthecochlea(C)(reproducedwithmodiﬁcationwith
permission from [26]).
formation. An animal model of cholesteatoma was made by
using these chemicals in guinea pigs or rats [42, 43].
Placing a mixture of talcum powder and ﬁbrin in the
bulla of a guinea pig results in a typical cholesteatoma.
It originates from the epidermal basal cells of the tym-
panic membrane and migrates into the middle ear. This
corroborates the epithelial migration theory [42]. Schmid
and Hellstrom [43] induced the cholesteatoma formation in
rats by using dimethyl-benzanthrancene (DMBA). DMBA
is a chemical carcinogen widely used for experimental
purposes [44]. After perforating the upper quadrant of the
tympanic membrane of a rat, the perforation was exposed
to DMBA four times at weekly intervals. They successfully
made a cholesteatoma formation in rats. Propylene glycol
(PG) has been shown to cause epithelial migration and
cholesteatomatous chronic otitis media in North-American
chinchillas using optic drops (Cortisporin) containing PG
(10%)[45].IncreasingthedoseofPGintopicalpreparations
injected transtympanically yields cholesteatomas [46, 47]i n
a progressively higher percentage of rats, reaching 100% at a
concentration of 90%.Journal of Biomedicine and Biotechnology 5
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Figure 5: Eustachian tube cauterization (reproduced with modiﬁcation with permission from Wolfman and Chole [27]). (a) Positioning of
supine animal (reproduced with modiﬁcation with permission from Wolfman and Chole [27]). (b) Cautery tip introduced through midline
of soft palate and directed laterally. Eustachian tube oriﬁce is approximately 5mm posterior to junction of hard and soft palates (reproduced
with modiﬁcation with permission from Wolfman and Chole [27]).
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Figure 6: Diagram of coronal section through bulla of gerbil written by Wolfman and Chole [27]. (a) Normal gerbil (reproduced with
modiﬁcation with permission from Wolfman and Chole [27]). (b) After Eustachian tube cauterization, eﬀusion develops (shaded area) and
tympanic membrane retracts (reproduced with modiﬁcation with permission from Wolfman and Chole [27]). (c) With time, pars ﬂaccida
retracts into deep pockets, where keratin accumulates (arrows) (reproduced with modiﬁcation with permission from Wolfman and Chole
[27]).
Several studies were done in another to establish new
therapies as alternative to surgery for middle ear cholestea-
tomas using these models. After producing a cholesteatoma
in chinchillas by using PG (60%), 5-ﬂuorouracil was used
to inhibit growth of the cholesteatoma with satisfactory
results [48]. Hyaluronic acid was applied to the external
ear of chinchillas in an attempt to inhibit PG-induced
cholesteatoma development with poor results [49]. Simi-
larly, poor results were seen when using cyclophosphamide
systemically in chinchillas [50] .T h el o c a lu s eo ft h et r a n -
sretinoic acid is eﬀective in inhibiting the induced formation
of cholesteatomas in guinea pigs [51].
5.Biological MaterialInjectioninto
t h eM id dl eEarint h eM o n g o l ianGe rb il ,
GuineaPigandRat
Cholesteatoma is a squamous cell cyst, characterized by
keratinizing epidermal tissue that can migrate and erode to6 Journal of Biomedicine and Biotechnology
adjacent structures frequently found in temporal bones. An
animal model of cholesteatoma was made by using dermal
tissues in the middle ears of animals [52–54]. Mongolian
gerbils, guinea pigs and rats were used in this experiment.
After each animal was anesthetized, a retroauricular skin
incision was made following abrasion of the graft in the
opposite ear. The dorsal bulla was opened, and the whole of
the mucosal lining was carefully removed. The graft, taken
from the external ear canal or from other parts of the body,
was then placed so that the subepithelial plane faced the
exposed bone. The opening of the bulla was covered with a
piece of temporalis muscle and the wound sutured.
According to the results, full-thickness skin grafts trans-
planted into the middle ear with superimposed infections
induced expansive growth and cholesteatoma development
[52–54]. The success rate of cholesteatoma formation was
89.3%. But, these cholesteatoma did not cause bone erosion.
6. The Autologous Dermal Implantation
Mouse Model
To circumvent limitations of the previous models and
their unpredictable degree of bone resorption, Chole et al.
[55] developed a new model of bone resorption in mouse
calvarias using keratin particles.
Underanesthesia,murinekeratincollectedfromthenails
and fur of mice was implanted onto the dissected calvarium
of mature mice. The caused an activation of osteoclasts in
the adjacent bone in a manner similar to that seen in human
cholesteatoma and in particle-induced osteolysis (Figure 7)
[55]. This model was useful in investigating the pathological
bone remodeling related to cholesteatoma in a genetically
well-deﬁned animal. Many of the genes and their products
that control the inﬂammatory process are well characterized
in this mouse model.
Based on their ﬁndings, Sudhoﬀ et al. [56, 57] also used
this dermal implanting model to investigate bone resorption
observed in middle ear cholesteatoma. They concluded that
the dermal implant tissue remained viable and produced
a robust, localized inﬂammatory osteolytic response on
the adjacent calvarial surface and that osteoclasts were
predominantly found on the surface of the calvarium with
the greatest osteoclast density under the increased expression
of osteoprotegerin (OPG), OPG ligand, and macrophage-
colony stimulating factor.
7. A LocalHybridEar Model of
ExperimentallyInducedCholesteatoma in
the Mongolian Gerbil
To investigate the origin of the epithelial cells of choleste-
atoma, whether from the epithelial cells of the external
auditory canal or the tympanic membrane, in a previous
study,wedescribedanewanimalmodelnamed“localhybrid
ear model” and used in situ PCR, which can detect a few
copies of genes within a cell in the section by amplifying the
target gene [58, 59].
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Figure 7: Inﬂammatory response typical of the site of keratin
implant at 1 week survival (reproduced with modiﬁcation with
permissionfromCholeetal.[55]).Theirregularsurfaceofthebone
(arrows) is suggestive of erosion though few surface osteoclasts are
seen at this time (reproduced with modiﬁcation with permission
from Chole et al. [55]). New vessels (v) are evident, and, at
higher power (inset, (b)), the remains of keratin debris (k) can
be seen surrounded by macrophages, lymphocytes, and giant cells
(reproduced with modiﬁcation with permission from Chole et al.
[55]).
Cholesteatomas were induced in gerbils with trans-
planted tympanic membranes using the ear auditory canal
ligation method. After the pars ﬂaccida of the tympanic
membranes were completely removed from male gerbils,
corresponding portions of tympanic membranes obtained
from the ear of female gerbils were transplanted to the area
of defect in the tympanic membranes. We then ligated the
external auditory canal of the “hybrid-model” group. As a
control group, the ear auditory canal of normal male and
female gerbils was ligated without previous myringoplasty.
Cholesteatomas were produced in all ears of each group.
The origin of cholesteatoma cells was analyzed by the
identiﬁcation of male (XY) or female (XX) cells in the
tissue section. Thus, in situ PCR was performed to detect
the mouse X-chromosome-linked phosphoglycerate kinase-
1 (pgk-1) gene on the paraﬃns e c t i o n s[ 60–62]. As a result,Journal of Biomedicine and Biotechnology 7
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Figure 8: In situ PCR in local hybrid ear model and control (reproduced with modiﬁcation with permission from Yamamoto-Fukuda et
al. [58]). (a) One pgk-1 spot in the nuclei of epithelial cells was detected in male. (b) One or two pgk-1 spot(s) were detected in female
cholesteatoma, respectively (reproduced with modiﬁcation with permission from Yamamoto-Fukuda et al. [58]). (c) One or two pgk-1
spot(s) were detected in the epithelial nuclei of cholesteatoma (reproduced with modiﬁcation with permission from Yamamoto-Fukuda et
al. [58]). (d) On the other hand, one pgk-1 spot was detected in the cells of EAC (reproduced with modiﬁcation with permission from
Yamamoto-Fukuda et al. [58]). Magniﬁcation, ×350. Green arrows: two spots. Blue arrows: one spot.
one pgk-1 spot in the epithelial nuclei was detected in male
cholesteatoma (Figure 8(a)), and one or two pgk-1 spots
were detected in female cholesteatoma (Figure 8(b)). On the
other hand, in the hybrid-model group, we detected not
only one but two pgk-1 spots in the epithelial nuclei of
cholesteatoma (Figure 8(c))andonepgk-1spotwasdetected
in the cells of the ear auditory canal (Figure 8(d)). The
percentage of the number of cells having one pgk-1 spot
or two pgk-1 spots of cholesteatoma in the hybrid model
was almost the same as that of female cholesteatoma. These
results indicated that all cholesteatoma cells in the hybrid
m o d e lh a v eX Xc h r o m o s o m e st h a tw e r ef e m a l et i s s u eo r i g i n .
Theresultsstronglydemonstratedevidencethattheorigin of
epithelial cells in cholesteatoma is the tympanic membrane,
not residential middle ear epithelial cells or the skin of the
external ear canal, in this hybrid model of cholesteatoma.
8. Conclusion and FutureProspects for
Animal Models
Animal model studies on the pathogenesis of cholesteatoma
have led to an improved comprehension of this disease.
Mongolian gerbils have a remarkable propensity for the
development of aural cholesteatoma; canal cholesteatomas
developspontaneouslyinagedanimals.Cholesteatomaswere
produced by ﬁve diﬀerent methods of induction: (1) ligation
of the external ear canal, (2) Eustachian tube blocking, (3)
chemical or free skin graft injection into the middle ear, (4)
the autologous dermal implantation model, and (5) a local
hybrid-ear model of experimentally induced cholesteatoma.
As shown in Table 1, we summarized the advantages and
disadvantages of each model. Depending upon the purpose
of studying the pathogenesis of cholesteatoma, we should
select an appropriable model among them.
In the previous study, gerbilline cholesteatomas induced
by these three methods (method 1∼method 3) were com-
pared by Kim and Chole [63]. These animal models proved
to be useful and informative regarding retraction pocket
formation and cholesteatoma development. As a result, the
appearanceratesofcholesteatomain eachgroupwerealmost
the same, but the patterns of epithelial hyperplasia, keratin
accumulation, thickening of the tympanic membrane, and
adhesions of the tympanic membrane were diﬀerent among
the three groups. Also, in 2002, Kim et al. [64]d e t e c t e d
prominent changes in the expression of markers for migra-
tion and hyperproliferation in gerbilline cholesteatomas
produced by three methods compared with that in the tym-
panic membrane, and their results supported the epidermal
migration theory. As in their previous study, the expression
patterns of epithelial markers in gerbilline cholesteatomas
produced by the three methods were not similar. They
concluded that each of the three methods of inducing
cholesteatoma may be helpful in investigating diﬀerent
clinical aspects of this disease. On the other hand, in 2007,
Choufani et al. [65] performed the quantitative comparison
of eight biological markers involved in inﬂammation, cell
diﬀerentiation, and cell adhesion/apoptosis between sections
of the ligated external ear canal animal model (Method
1) and clinical specimen. Their results indicated that the
majority of staining parameters was statistically signiﬁcantly
diﬀerent between sections of the animal model and clinical
specimen from the panel of the above markers. They
concluded that from a surgical point of view, this model was
easy to handle, with a high percentage of success, thereby
allowing one to quickly obtain an external auditory duct
cholesteatoma. However, these data did not support the
concept of complete validity of the popular animal model.
The problem with the previous method 1 to method
3 animal models was that the morphological aspects were
almost the same as human cholesteatoma, but the immun-
ohistochemical results were not strictly the same. In the
recent study, we modiﬁed the auditory canal ligation model
to investigate the origin of the cholesteatoma cells [58]. We
analyzed spontaneously occurring cholesteatomas associated
with a new transplantation model in gerbils, and using
pgk-1 as a tracer provided evidence that transplanted
tympanic membranes were the origin of the epithelial cells
associated with the development of auditory canal-ligated8 Journal of Biomedicine and Biotechnology
Table 1: Comparison of advantages among experimental cholesteatoma models.
Purpose of analysis Specie Surgery
Percentage of
cholesteatoma
occurrence
Advantage
(1) Ligation of
the external ear
canal
Epithelial migration
theory
Mongolian
gerbil Easy High Easy to handle
(2) Eustachian
tube blocking
Retraction pocket
theory
Mongolian
gerbil
Slightly
diﬃcult Moderate Useful for analysis of
inﬂammatory mediators
(3) Chemical
injection into the
middle ear
Cholesteatomatous
chronic otitis media
Chinchilla
Guinea-pig Rat Easy High Useful for administering
study
(4) Biological
material injection
into the middle
ear
Immigration theory
Mongolian
gerbil
Guinea-pig Rat
Slightly
diﬃcult Moderate Useful for analysis of
immigratrion theory
(5) Autologous
dermal
implantation
Bone destruction Mouse Slightly
diﬃcult High
Useful for investigate
pathological mechanism
of bone destruction
(6) Local hybrid
ear model
Origin of the
epithelial cells of
cholesteatoma
Mongolian
gerbil Diﬃcult High
Can demonstrate the
origin of the cells of
cholesteatoma correctly
cholesteatomas in gerbils. The results strongly demonstrated
that the origin of epithelial cells in cholesteatoma is the
tympanic membrane, but not residential middle ear epithe-
lial cells or the skin of the external ear canal in this
hybrid model of cholesteatoma. Accordingly, other studies
revealed diﬀerent protein and cytokeratin proﬁles between
cholesteatomakeratinocytesandepithelialcellsofthemiddle
ear [66, 67].
Currently, the retraction and proliferation theory has
many supporters following clinical observation. Habitual
sniﬃng has clinically been observed to increase the risk of
developing retraction pockets and cholesteatoma [68, 69].
Recently, the habitual sniﬃng-simulating model in gerbils
was made by Von Unge and Dircks [70]. The retraction
of the tympanic membrane was found, but cholesteatoma
formation did not appear. The retraction and proliferation
theory is a pathogenesis that combines the retraction caused
by otitis media or habitual sniﬃng and the proliferation
of the epithelial cells in the retraction pocket altered by
inﬂammatory stimuli of the subepithelial connective tissue.
Therefore, some improvement will be needed to investigate
the retraction and proliferation theory using this habitual
sniﬃng model.
Based on the results of inﬂammatory changes in clinical
cholesteatoma specimens, we would like to develop a new
animal model in the future. In our previous study, we
indicated that keratinocyte growth factor (KGF)/ﬁbroblast
growth factor-7 plays an important role in cholesteatoma
formation[71].KGFisamesenchymalcell-derivedparacrine
growth factor that speciﬁcally stimulates epithelial cell
growth and is supposed to be secreted from ﬁbroblasts
mainly in stroma binding to KGF receptor, which has only
been detected on the surface of epithelial cells [72, 73].
On the other hand, direct in vivo plasmid DNA transfer
to the skin via injection has been reported previously [74,
75], and transfer of DNA using electroporation [76]h a s
been demonstrated as a useful procedure for the short-term
delivery of gene therapy. We will use KGF-CMV-14 vector
[77] and cause overexpression of KGF by electroporatively
transfected KGF cDNA in the cells of epithelial tissues in
vivo. A single injection of KGF cDNA-expressive vector
coupled with electroporation will enhance inﬂammatory
reaction and increase keratinization of epithelium in the
auditorycanal.Thismodelcanpossiblybeusedtoinvestigate
the eﬀects of various cytokines and growth factors in
cholesteatoma formation in vivo.
The goal of the experiments using animal models is to
analyze the pathogenesis of cholesteatoma. Of course, we
know that biological diﬀerences between animal models and
human cholesteatoma would make it diﬃcult to understand
the pathogenesis of human cholesteatoma. More suitable
models for middle ear cholesteatoma will be needed for
future study.
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